773 related articles for article (PubMed ID: 31200447)
1. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
[TBL] [Abstract][Full Text] [Related]
3. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Özenver N; Efferth T
Pharmacol Res; 2021 Aug; 170():105710. PubMed ID: 34089866
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Role of Berberine, an Isoquinoline Alkaloid, on NLRP3 Inflammasome Activation for the Treatment of Inflammatory Diseases.
Sarbadhikary P; George BP; Abrahamse H
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684819
[TBL] [Abstract][Full Text] [Related]
5. Targeting the NLRP3 Inflammasome in Neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders.
Hung WL; Ho CT; Pan MH
Mol Nutr Food Res; 2020 Feb; 64(4):e1900550. PubMed ID: 31675164
[TBL] [Abstract][Full Text] [Related]
6. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review.
Olcum M; Tastan B; Ercan I; Eltutan IB; Genc S
Phytomedicine; 2020 Aug; 75():153238. PubMed ID: 32507349
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
Zhao N; Li CC; Di B; Xu LL
J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
[TBL] [Abstract][Full Text] [Related]
10. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion.
Ho SC; Chang YH
Molecules; 2018 Feb; 23(2):. PubMed ID: 29466287
[TBL] [Abstract][Full Text] [Related]
12. Quinones as preventive agents in Alzheimer's diseases: focus on NLRP3 inflammasomes.
Chen DB; Gao HW; Peng C; Pei SQ; Dai AR; Yu XT; Zhou P; Wang Y; Cai B
J Pharm Pharmacol; 2020 Nov; 72(11):1481-1490. PubMed ID: 32667050
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication.
Jhang JJ; Lin JH; Yen GC
J Agric Food Chem; 2018 Jan; 66(4):765-772. PubMed ID: 29293001
[TBL] [Abstract][Full Text] [Related]
14. Focus on the Role of NLRP3 Inflammasome in Diseases.
Fusco R; Siracusa R; Genovese T; Cuzzocrea S; Di Paola R
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545788
[TBL] [Abstract][Full Text] [Related]
15. Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation.
Pellegrini C; Antonioli L; Lopez-Castejon G; Blandizzi C; Fornai M
Front Immunol; 2017; 8():36. PubMed ID: 28179906
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implications.
Pellegrini C; Martelli A; Antonioli L; Fornai M; Blandizzi C; Calderone V
Med Res Rev; 2021 Jul; 41(4):1890-1926. PubMed ID: 33460162
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
[TBL] [Abstract][Full Text] [Related]
18. The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways.
Jiang D; Chen S; Sun R; Zhang X; Wang D
Cancer Lett; 2018 Apr; 419():8-19. PubMed ID: 29339210
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
Tao S; Fan W; Liu J; Wang T; Zheng H; Qi G; Chen Y; Zhang H; Guo Z; Zhou F
J Alzheimers Dis; 2023; 96(4):1383-1398. PubMed ID: 37980662
[TBL] [Abstract][Full Text] [Related]
20. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
Wang S; Yuan YH; Chen NH; Wang HB
Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
